The computerized on-line Medicaid pharmaceutical analysis and surveillance system: a new resource for postmarketing drug surveillance.

Suppr

超能文献

作者信息

Strom B L, Carson J L, Morse M L, LeRoy A A

出版信息

Clin Pharmacol Ther. 1985 Oct;38(4):359-64. doi: 10.1038/clpt.1985.188.

DOI:10.1038/clpt.1985.188

PMID:3899458

Abstract

摘要

相似文献

The computerized on-line Medicaid pharmaceutical analysis and surveillance system: a new resource for postmarketing drug surveillance.

Clin Pharmacol Ther. 1985 Oct;38(4):359-64. doi: 10.1038/clpt.1985.188.

Postmarketing surveillance methodologies.上市后监测方法。

Drug Intell Clin Pharm. 1988 Jan;22(1):68-78. doi: 10.1177/106002808802200117.

Post-marketing surveillance of new drugs.新药上市后监测

J R Coll Gen Pract. 1987 Aug;37(301):337-8.

Medicaid drug-event data: an emerging tool for evaluation of drug risk.

Acta Med Scand Suppl. 1984;683:127-34. doi: 10.1111/j.0954-6820.1984.tb08728.x.

The epidemiological evaluation of drugs.

Acta Med Scand Suppl. 1984;683:23-7. doi: 10.1111/j.0954-6820.1984.tb08710.x.

Techniques of postmarketing surveillance. An overview.上市后监测技术。概述。

Med Toxicol. 1986 Jul-Aug;1(4):237-46. doi: 10.1007/BF03259840.

[Postmarketing surveillance of drugs].

Rev Prat. 1983 Jan 1;33(1-2):23-8.

Statewide test of a new postmarketing drug surveillance system.一种新的上市后药品监测系统的全州范围测试。

Tex Med. 1987 Aug;83(8):59-62.

Postmarketing surveillance of adverse drug reactions: problems and solutions.药品不良反应的上市后监测：问题与解决方案

CMAJ. 1986 Jul 1;135(1):27-32.

What you should know about FDA-USP Drug Product Problem Reporting Program.

Pharm Times. 1986 Apr;52(4):101-4, 109.

引用本文的文献

Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial.药物安全研究的医疗保健数据库：数据有效性评估仍然至关重要。

Drug Saf. 2018 Sep;41(9):829-833. doi: 10.1007/s40264-018-0673-z.

Signal Detection for Recently Approved Products: Adapting and Evaluating Self-Controlled Case Series Method Using a US Claims and UK Electronic Medical Records Database.近期获批产品的信号检测：使用美国索赔和英国电子病历数据库对自我对照病例系列方法进行调整和评估。

Drug Saf. 2018 May;41(5):523-536. doi: 10.1007/s40264-017-0626-y.

CNODES: the Canadian Network for Observational Drug Effect Studies.CNODES：加拿大药物效应观察研究网络。

Open Med. 2012 Oct 30;6(4):e134-40. Print 2012.

Prescription pricing databases should include more details to assess prescribing rationality.处方定价数据库应包含更多细节以评估处方合理性。

BMJ. 2001 Jan 20;322(7279):173-4.

Drug utilisation studies as tools in health economics.药物利用研究作为卫生经济学中的工具。

Pharmacoeconomics. 1994 Apr;5(4):299-312. doi: 10.2165/00019053-199405040-00005.

Pharmacoeconomic consequences of measurement and modification of hospital drug use.医院用药计量与调整的药物经济学后果

Pharmacoeconomics. 1992 Jul;2(1):15-33. doi: 10.2165/00019053-199202010-00004.

Race and hypertension. What is clinically relevant?种族与高血压。临床上有何关联？

Drugs. 1994 Jun;47(6):914-32. doi: 10.2165/00003495-199447060-00005.

Postmarketing surveillance of adverse drug reactions: problems and solutions.药品不良反应的上市后监测：问题与解决方案

CMAJ. 1986 Jul 1;135(1):27-32.

Techniques of postmarketing surveillance. An overview.上市后监测技术。概述。

Med Toxicol. 1986 Jul-Aug;1(4):237-46. doi: 10.1007/BF03259840.

Patients as a direct source of information on adverse drug reactions.患者作为药物不良反应信息的直接来源。

BMJ. 1988 Oct 8;297(6653):891-3. doi: 10.1136/bmj.297.6653.891.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验